Print Page   |   Contact Us   |   Your Cart   |   Sign In
Sign In

Breaking News
OSAP 2015 Symposium Dr. John Zapp Memorial Lecture: Diseases Update, C-Diff and Antibiotic Resistanc

OSAP 2015 Symposium: Infection Control - Gaining the Edge

TITLE    Dr. John Zapp Memorial Lecture: Diseases Update, C-Diff and Antibiotic  Resistance




Infectious diseases are constantly changing with new or variant forms emerging and potentially impacting oral healthcare delivery. The CDC has recently responded to threats of Middle East Respiratory Syndrome (MERS) and Ebola; major aspects of these responses and outpatient infection control guidance will be discussed. Meanwhile, antibiotics have proven a transformative technology for all of healthcare, yet our collective lease on their benefits is running out and instances of net harm from their overuse are becoming increasingly evident. CDC’s 2013 Antibiotic Resistance Threat Report highlighted 18 urgent, serious, and concerning threats; although none commonly cause oral infection, all are amplified by unnecessary antibiotic use. The epidemiology of Clostridium difficile changed dramatically 15 years ago when a hyper virulent strain emerged, driving rates and associated deaths to historic highs. Now there is a tremendous burden of CDI in both inpatient and community populations and the role of antibiotic use for oral healthcare will be discussed.





L. Clifford McDonald, MD FACP FSHEA






After attending this program, participants should be able to:

  • Recall major aspects in the epidemiology of recent global outbreaks of serious viral disease (i.e. SARS, H1N1, MERS, Ebola) and how they impact infection control for ambulatory settings, including oral healthcare delivery settings.
  • List the urgent threats from the 2013 Antibiotic Resistance Threat Report as well as serious and concerning threats with greatest relevance to oral healthcare and explain how antibiotic use amplifies all resistance threats.
  • Identify major aspects in the epidemiology of Clostridium difficile infections and interpret existing evidence for the role of oral healthcare delivery in this epidemiology. 





OSAP Disclaimer | Please notify our webmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2018. Sponsorship does not imply endorsement by OSAP of a company's products or services.